Obsidian Therapeutics (OBX) Stock Analysis

What Obsidian Therapeutics does

A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.

Key metrics

ETFs linked to OBX

Broad-market and Healthcare sector ETFs an investor holding Obsidian Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OBX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Obsidian Therapeutics?

Obsidian Therapeutics trades under the ticker OBX on NASDAQ.

Which exchange is OBX listed on?

OBX is listed on NASDAQ.

What sector does Obsidian Therapeutics operate in?

Obsidian Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OBX in a portfolio?

PortView shows OBX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.